Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 4066 AL 4080

[Pathophysiological and neurobiological basis for the development of depression in patients with Parkinson's disease]

Sayfitdinkhuzhaev ZF, Zhukova NG, Nasyrova RF, Gaponova OV, Zhukova IA, Masenko AY, Baydanova AN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(1):7-12. doi: 10.17116/jnevro20261260117.

The potential role of adenosinergic pathway and methylxanthines in Parkinson's disease: Blowing in the wind or not

Ismail A, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Alkazmi LM, Albukhari AF, Shokr MM, Alexiou A, Papadakis M, Batiha GE.

Purinergic Signal. 2026 Mar 9;22(2):24. doi: 10.1007/s11302-025-10114-6.

Models of neuroprotection in Parkinson's disease: Exploring cellular, molecular, and microenvironmental targets

Álvarez-Luquín DD, González-Fernández RR, Ichikawa-Escamilla E, Torres-Velasco ME, Martínez-Martínez E, Arce-Sillas A, Juárez-Vaquera VH, Miranda-Narvaez CL, Hernández M, Adalid-Peralta L.

Exp Neurol. 2026 Aug;402:115764. doi: 10.1016/j.expneurol.2026.115764. Epub 2026 Apr 11.

[Research progress on intelligent brain age prediction methods in diagnosis of Parkinson's disease]

Zheng S, Zhang Y, Zhang Q, Hao Z, Yang Y, Zhou L, Yao X.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2026 Apr 25;43(2):421-427. doi: 10.7507/1001-5515.202504010.

A new dawn for Parkinson's disease: commentary on the emergence of stem cell-based therapies

Elvira R, Chooi WH, Wang H, Tan EK, Zhou ZD.

Transl Neurodegener. 2026 Apr 29;15(1):20. doi: 10.1186/s40035-026-00556-2.

Programmed cell death pathways in Parkinson's disease: Spotlight on ferroptosis and pyroptosis

Sharma V, Verma R, Sharma P, Singh TG.

Brain Res. 2026 Mar 15;1875:150165. doi: 10.1016/j.brainres.2026.150165. Epub 2026 Jan 11.

Validation of a Patient-Reported Outcome Measure in Parkinson's Disease

Mischley LK, Murawska M.

Nutrients. 2026 Mar 31;18(7):1118. doi: 10.3390/nu18071118.

Moral decision-making in patients with neurodegenerative diseases: a systematic review

Capitani G, Lozzi D, Curcio G, Migliore S.

Front Psychol. 2026 Feb 12;17:1745923. doi: 10.3389/fpsyg.2026.1745923. eCollection 2026.

Movement Disorders in Cabo Verde: Epidemiology, Access Barriers, and Public Health Implications in an Aging Island Population

Tolentino LC, Monteiro JFG, Brito Pires C, Fortes A.

Int J Public Health. 2026 Mar 3;71:1608728. doi: 10.3389/ijph.2026.1608728. eCollection 2026.

Protocol for using an ELISA to detect total α-synuclein levels in Drosophila melanogaster lines expressing human α-synuclein point mutations

Sciortino M, Velazquez R, Tillmon H, Banerjee S.

bioRxiv [Preprint]. 2026 May 15:2026.01.07.698009. doi: 10.64898/2026.01.07.698009.

An evolutionary view on the developing prefrontal cortex connectome and its psychopathological networks: Tract tracing and imaging studies linking two distant anthropoid species

Coenen VA, Rau A, Watakabe A, Skibbe H, Yamamori T, Schläpfer TE, Czornik M, Meyer-Doll D, Endres D, Baldermann JC, Urbach H, Döbrössy MD, Sajonz BEA, Reisert M.

Res Sq [Preprint]. 2026 Feb 10:rs.3.rs-8755074. doi: 10.21203/rs.3.rs-8755074/v1.

Deep brain stimulation reduces subthalamic nucleus pathological dynamics and rescues gait deficits associated with dopamine loss

Steiner L, Darie R, Lindsay A, Tseng HA, van Welie I, Han X.

bioRxiv [Preprint]. 2026 Mar 18:2026.03.17.712325. doi: 10.64898/2026.03.17.712325.

Pharmacological insights into deoxyelephantopin: a multifunctional sesquiterpene with therapeutic promise in cancer and neurodegenerative disorders

Priyadarshni A, Sharma R, Bora KS, Dewangan HK.

Mol Biol Rep. 2026 Apr 10;53(1):604. doi: 10.1007/s11033-026-11700-6.

Faecal microbiota transplant for Parkinson's disease: promises and future directions

Tan EK, Wang JDJ, Pettersson S, Wang Q, Takahashi R, Poewe W, Jankovic J, Rascol O.

Brain. 2026 Jan 8;149(1):59-70. doi: 10.1093/brain/awaf419.

In vivo Proximity & Spatial Proteomics with CRISPR Screening Identify STXBP1 as a Protective Modifier of α-synuclein Toxicity in Dopamine Neurons

Shonai D, Kent J, Okafor A, Gao Y, Parameswaran P, Bustamante E, Ramani B, Diao Y, Kampmann M, Soderblom E, Soderling S.

bioRxiv [Preprint]. 2026 Jan 17:2026.01.16.699530. doi: 10.64898/2026.01.16.699530.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias